Gene · 3872
Papers3,832
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,832
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Study of Preparation and Properties of Stereoregular Poly(cyclohexenylene carbonate). | Molecules | 2023 | 37446895 | PubTator, text mining | PubMed |
| A Sequential Micro-Immunotherapy Medicine Increases Collagen Deposition in Human Gingival Fibroblasts and in an Engineered 3D Gingival Model under Inflammatory Conditions. | Int J Mol Sci | 2023 | 37445663 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival. | Cancers (Basel) | 2023 | 37444550 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma. | Medicine (Baltimore) | 2023 | 37443495 | PubTator, text mining | PubMed |
| Transcriptional Profile of Human Pancreatic Acinar Ductal Metaplasia. | Gastro Hep Adv | 2023 | 37425649 | PubTator, text mining | PubMed |
| Spatial Multiomics Analysis in Psychiatric Disorders. | EC Psychol Psychiatr | 2023 | 37424930 | PubTator, text mining | PubMed |
| Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low-Concentration Collagen-Based Bioinks. | Adv Healthc Mater | 2023 | 37422447 | PubTator, text mining | PubMed |
| Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy. | Front Mol Biosci | 2023 | 37405259 | PubTator, text mining | PubMed |
| Synovial sarcoma of female urethra: a case report and review of the literature. | Diagn Pathol | 2023 | 37400856 | PubTator, text mining | PubMed |
| Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. | Front Oncol | 2023 | 37397364 | PubTator, text mining | PubMed |
| Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation. | J Dermatol | 2023 | 37392066 | PubTator, text mining | PubMed |
| RETRACTED: Expression of microRNAs and their target genes in melanomas originating from gynecologic sites. | PLoS One | 2023 | 37384650 | PubTator, text mining | PubMed |
| Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers. | Iran J Pathol | 2023 | 37383162 | PubTator, text mining | PubMed |
| Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review. | Am J Case Rep | 2023 | 37381599 | PubTator, text mining | PubMed |
| Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association. | J Pers Med | 2023 | 37373937 | PubTator, text mining | PubMed |
| Genetics of Generalized Pustular Psoriasis: Current Understanding and Implications for Future Therapeutics. | Genes (Basel) | 2023 | 37372477 | PubTator, text mining | PubMed |
| The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. | Cells | 2023 | 37371141 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals Candidate Ligand-Receptor Pairs and Signaling Networks Mediating Intercellular Communication between Hair Matrix Cells and Dermal Papilla Cells from Cashmere Goats. | Cells | 2023 | 37371115 | PubTator, text mining | PubMed |
| scRNA-Seq of Cultured Human Amniotic Fluid from Fetuses with Spina Bifida Reveals the Origin and Heterogeneity of the Cellular Content. | Cells | 2023 | 37371048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3872/papers?page=23